Joe Avellone, MD

Dr. Avellone, is on the Boards of Directors of MMS, Apnimed, Clinical Ink, Celerion, and Biorasi. He has previously served on the Board of Cytel.

For the prior 10 years, on the Executive Management team of PAREXEL International, Dr. Avellone was responsible for the global management of PAREXEL’s Early Phase, Phase II-IV, Medical Affairs and Clinical Logistics Services business units. His responsibilities included the oversight of all aspects of clinical trial conduct throughout the Americas, Europe, Africa, and Asia/Pacific regions.

Prior to joining PAREXEL, Dr. Avellone was Chief Executive Officer of Veritas Medicine, a healthcare technology company supporting clinical trials. Previously, he served as Chief Operating Officer of BlueCross BlueShield of Massachusetts. Dr. Avellone is a Fellow of the American College of Surgeons. He received his M.D. from the Harvard Medical School and completed his General Surgery Residency at Brigham and Women’s Hospital. He also received a Master’s in Public Administration from the John F. Kennedy School of Government at Harvard University, and a Bachelor’s of the Arts from Dartmouth College.

Prior Board experiences have included: Boston Heart Diagnostics, Blue Cross and Blue Shield of Massachusetts, and Boston Healthcare for the Homeless Program.